Neumann FJ, Sousa-Uva M, Ahlsson A, Alfonso F, Banning AP, Benedetto U, Byrne RA, Collet JP, Falk V, Head SJ, et al: 2018 ESC/EACTS guidelines on myocardial revascularization. Eur Heart J. 40:87–165. 2019.PubMed/NCBI View Article : Google Scholar

Knuuti J, Wijns W, Saraste A, Capodanno D, Barbato E, Funck-Brentano C, Prescott E, Storey RF, Deaton C, Cuisset T, et al: 2019 ESC guidelines for the diagnosis and management of chronic coronary syndromes. Eur Heart J. 41:407–477. 2020.PubMed/NCBI View Article : Google Scholar

Collet JP, Thiele H, Barbato E, Barthelemy O, Bauersachs J, Bhatt DL, Dendale P, Dorobantu M, Edvardsen T, Folliguet T, et al: 2020 ESC guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation. Eur Heart J ehaa575, 2020.

Gruntzig AR, Senning A and Siegenthaler WE: Nonoperative dilatation of coronary-artery stenosis: Percutaneous transluminal coronary angioplasty. N Engl J Med. 301:61–68. 1979.PubMed/NCBI View Article : Google Scholar

McKavanagh P, Zawadowski G, Ahmed N and Kutryk M: The evolution of coronary stents. Expert Rev Cardiovasc Ther. 16:219–228. 2018.PubMed/NCBI View Article : Google Scholar

Huang KN, Grandi SM, Filion KB and Eisenberg MJ: Late and very late stent thrombosis in patients with second-generation drug-eluting stents. Can J Cardiol. 29:1488–1494. 2013.PubMed/NCBI View Article : Google Scholar

Chang M and Park DW: Optimal duration of dual antiplatelet therapy after implantation of drug-eluting stents: Shorter or longer? Cardiol Ther. 3:1–12. 2014.PubMed/NCBI View Article : Google Scholar

Hassan AK, Bergheanu SC, Stijnen T, van der Hoeven BL, Snoep JD, Plevier JW, Schalij MJ and Wouter Jukema J: Late stent malapposition risk is higher after drug-eluting stent compared with bare-metal stent implantation and associates with late stent thrombosis. Eur Heart J. 31:1172–1180. 2010.PubMed/NCBI View Article : Google Scholar

Cassese S, Byrne RA, Tada T, Pinieck S, Joner M, Ibrahim T, King LA, Fusaro M, Laugwitz KL and Kastrati A: Incidence and predictors of restenosis after coronary stenting in 10 004 patients with surveillance angiography. Heart. 100:153–159. 2014.PubMed/NCBI View Article : Google Scholar

Byrne RA, Joner M and Kastrati A: Stent thrombosis and restenosis: What have we learned and where are we going? The andreas gruntzig lecture ESC 2014. Eur Heart J. 36:3320–3331. 2015.PubMed/NCBI View Article : Google Scholar

Madhavan MV, Kirtane AJ, Redfors B, Genereux P, Ben-Yehuda O, Palmerini T, Benedetto U, Biondi-Zoccai G, Smits PC, von Birgelen C, et al: Stent-related adverse events >1 year after percutaneous coronary intervention. J Am Coll Cardiol. 75:590–604. 2020.PubMed/NCBI View Article : Google Scholar

Loh JP, Pendyala LK, Kitabata H, Torguson R, Omar A, Minha S, Chen F, Satler LF, Pichard AD and Waksman R: Comparison of outcomes after percutaneous coronary intervention among different coronary subsets (stable and unstable angina pectoris and ST-segment and non-ST-segment myocardial infarction). Am J Cardiol. 113:1794–1801. 2014.PubMed/NCBI View Article : Google Scholar

Gonzalo N, Barlis P, Serruys PW, Garcia-Garcia HM, Onuma Y, Ligthart J and Regar E: Incomplete stent apposition and delayed tissue coverage are more frequent in drug-eluting stents implanted during primary percutaneous coronary intervention for ST-segment elevation myocardial infarction than in drug-eluting stents implanted for stable/unstable angina: Insights from optical coherence tomography. JACC Cardiovasc Interv. 2:445–452. 2009.PubMed/NCBI View Article : Google Scholar

Hung MJ, Hsu KH, Chang NC, Tsimikas S and Hung MY: Prevalence of coronary artery spasm after stent placement and its association with inflammation. Int J Cardiol. 179:252–255. 2015.PubMed/NCBI View Article : Google Scholar

Ang H, Lin J, Huang YY, Chong TT, Cassese S, Joner M and Foin N: Drug-Coated balloons: Technologies and clinical applications. Curr Pharm Des. 24:381–396. 2018.PubMed/NCBI View Article : Google Scholar

Jeger RV, Eccleshall S, Wan Ahmad WA, Ge J, Poerner TC, Shin ES, Alfonso F, Latib A, Ong PJ, Rissanen TT, et al: Drug-coated balloons for coronary artery disease: Third report of the international DCB consensus group. JACC Cardiovasc Interv. 13:1391–1402. 2020.PubMed/NCBI View Article : Google Scholar

Scheller B, Hehrlein C, Bocksch W, Rutsch W, Haghi D, Dietz U, Bohm M and Speck U: Treatment of coronary in-stent restenosis with a paclitaxel-coated balloon catheter. N Engl J Med. 355:2113–2124. 2006.PubMed/NCBI View Article : Google Scholar

Giacoppo D, Alfonso F, Xu B, Claessen BEPM, Adriaenssens T, Jensen C, Perez-Vizcayno MJ, Kang DY, Degenhardt R, Pleva L, et al: Paclitaxel-coated balloon angioplasty vs. drug-eluting stenting for the treatment of coronary in-stent restenosis: A comprehensive, collaborative, individual patient data meta-analysis of 10 randomized clinical trials (DAEDALUS study). Eur Heart J. 41:3715–3728. 2020.PubMed/NCBI View Article : Google Scholar

Rittger H, Brachmann J, Sinha AM, Waliszewski M, Ohlow M, Brugger A, Thiele H, Birkemeyer R, Kurowski V, Breithardt OA, et al: A randomized, multicenter, single-blinded trial comparing paclitaxel-coated balloon angioplasty with plain balloon angioplasty in drug-eluting stent restenosis: The PEPCAD-DES study. J Am Coll Cardiol. 59:1377–1382. 2012.PubMed/NCBI View Article : Google Scholar

Scheller B, Clever YP, Kelsch B, Hehrlein C, Bocksch W, Rutsch W, Haghi D, Dietz U, Speck U, Böhm M and Cremers B: Long-term follow-up after treatment of coronary in-stent restenosis with a paclitaxel-coated balloon catheter. JACC Cardiovasc Interv. 5:323–330. 2012.PubMed/NCBI View Article : Google Scholar

Jeger RV, Farah A, Ohlow MA, Mangner N, Mobius-Winkler S, Leibundgut G, Weilenmann D, Wohrle J, Richter S, Schreiber M, et al: Drug-coated balloons for small coronary artery disease (BASKET-SMALL 2): An open-label randomised non-inferiority trial. Lancet. 392:849–856. 2018.PubMed/NCBI View Article : Google Scholar

Cortese B, Micheli A, Picchi A, Coppolaro A, Bandinelli L, Severi S and Limbruno U: Paclitaxel-coated balloon versus drug-eluting stent during PCI of small coronary vessels, a prospective randomised clinical trial. The PICCOLETO study. Heart. 96:1291–1296. 2010.PubMed/NCBI View Article : Google Scholar

Latib A, Colombo A, Castriota F, Micari A, Cremonesi A, De Felice F, Marchese A, Tespili M, Presbitero P, Sgueglia GA, et al: A randomized multicenter study comparing a paclitaxel drug-eluting balloon with a paclitaxel-eluting stent in small coronary vessels: The BELLO (Balloon elution and late loss optimization) study. J Am Coll Cardiol. 60:2473–2480. 2012.PubMed/NCBI View Article : Google Scholar

Waksman R and Pakala R: Drug-eluting balloon: The comeback kid? Circ Cardiovasc Interv. 2:352–358. 2009.PubMed/NCBI View Article : Google Scholar

Wessely R: New drug-eluting stent concepts. Nat Rev Cardiol. 7:194–203. 2010.PubMed/NCBI View Article : Google Scholar

Axel DI, Kunert W, Goggelmann C, Oberhoff M, Herdeg C, Kuttner A, Wild DH, Brehm BR, Riessen R, Köveker G and Karsch KR: Paclitaxel inhibits arterial smooth muscle cell proliferation and migration in vitro and in vivo using local drug delivery. Circulation. 96:636–645. 1997.PubMed/NCBI View Article : Google Scholar

Yerasi C, Case BC, Forrestal BJ, Torguson R, Weintraub WS, Garcia-Garcia HM and Waksman R: Drug-coated balloon for de novo coronary artery disease: JACC state-of-the-art review. J Am Coll Cardiol. 75:1061–1073. 2020.PubMed/NCBI View Article : Google Scholar

Cheng Y, Leon MB and Granada JF: An update on the clinical use of drug-coated balloons in percutaneous coronary interventions. Expert Opin Drug Deliv. 13:859–872. 2016.PubMed/NCBI View Article : Google Scholar

Verheye S, Vrolix M, Kumsars I, Erglis A, Sondore D, Agostoni P, Cornelis K, Janssens L, Maeng M, Slagboom T, et al: The SABRE trial (Sirolimus angioplasty balloon for coronary in-stent restenosis): Angiographic results and 1-year clinical outcomes. JACC Cardiovasc Interv. 10:2029–2037. 2017.PubMed/NCBI View Article : Google Scholar

Ali RM, Abdul Kader MASK, Wan Ahmad WA, Ong TK, Liew HB, Omar AF, Mahmood Zuhdi AS, Nuruddin AA, Schnorr B and Scheller B: Treatment of coronary drug-eluting stent restenosis by a sirolimus- or paclitaxel-coated balloon. JACC Cardiovasc Interv. 12:558–566. 2019.PubMed/NCBI View Article : Google Scholar

Cortese B, Di Palma G and Latini R: Magic Touch^(R): Preliminary clinical evidence with a novel sirolimus drug coated balloon. Minerva Cardioangiol. 66:508–517. 2018.PubMed/NCBI View Article : Google Scholar

Scheller B, Speck U, Abramjuk C, Bernhardt U, Bohm M and Nickenig G: Paclitaxel balloon coating, a novel method for prevention and therapy of restenosis. Circulation. 110:810–814. 2004.PubMed/NCBI View Article : Google Scholar

Ibanez B, James S, Agewall S, Antunes MJ, Bucciarelli-Ducci C, Bueno H, Caforio ALP, Crea F, Goudevenos JA, Halvorsen S, et al: 2017 ESC Guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation: The Task Force for the management of acute myocardial infarction in patients presenting with ST-segment elevation of the European society of cardiology (ESC). Eur Heart J. 39:119–177. 2018.PubMed/NCBI View Article : Google Scholar

Alawami M, Sadler M, Kasargod C, Watson T, Webster M and Ruygrok P: Outcomes of patients with ST elevation myocardial infarction in the era of second-generation drug eluting stents; five-year follow-up. N Z Med J. 132:34–41. 2019.PubMed/NCBI

Herdeg C, Oberhoff M, Baumbach A, Blattner A, Axel DI, Schroder S, Heinle H and Karsch KR: Local paclitaxel delivery for the prevention of restenosis: Biological effects and efficacy in vivo. J Am Coll Cardiol. 35:1969–1976. 2000.PubMed/NCBI View Article : Google Scholar

Oberhoff M, Kunert W, Herdeg C, Kuttner A, Kranzhofer A, Horch B, Baumbach A and Karsch KR: Inhibition of smooth muscle cell proliferation after local drug delivery of the antimitotic drug paclitaxel using a porous balloon catheter. Basic Res Cardiol. 96:275–282. 2001.PubMed/NCBI View Article : Google Scholar

Ho HH, Tan J, Ooi YW, Loh KK, Aung TH, Yin NT, Sinaga DA, Jafary FH and Ong PJ: Preliminary experience with drug-coated balloon angioplasty in primary percutaneous coronary intervention. World J Cardiol. 7:311–314. 2015.PubMed/NCBI View Article : Google Scholar

Vos NS, Dirksen MT, Vink MA, van Nooijen FC, Amoroso G, Herrman JP, Kiemeneij F, Patterson MS, Slagboom T and van der Schaaf RJ: Safety and feasibility of a PAclitaxel-eluting balloon angioplasty in Primary Percutaneous coronary intervention in Amsterdam (PAPPA): One-year clinical outcome of a pilot study. EuroIntervention. 10:584–590. 2014.PubMed/NCBI View Article : Google Scholar

Gobic D, Tomulic V, Lulic D, Zidan D, Brusich S, Jakljevic T and Zaputovic L: Drug-coated balloon versus drug-eluting stent in primary percutaneous coronary intervention: A feasibility study. Am J Med Sci. 354:553–560. 2017.PubMed/NCBI View Article : Google Scholar

Belkacemi A, Agostoni P, Nathoe HM, Voskuil M, Shao C, Van Belle E, Wildbergh T, Politi L, Doevendans PA, Sangiorgi GM and Stella PR: First results of the DEB-AMI (drug eluting balloon in acute ST-segment elevation myocardial infarction) trial: A multicenter randomized comparison of drug-eluting balloon plus bare-metal stent versus bare-metal stent versus drug-eluting stent in primary percutaneous coronary intervention with 6-month angiographic, intravascular, functional, and clinical outcomes. J Am Coll Cardiol. 59:2327–2337. 2012.PubMed/NCBI View Article : Google Scholar

Nijhoff F, Agostoni P, Belkacemi A, Nathoe HM, Voskuil M, Samim M, Doevendans PA and Stella PR: Primary percutaneous coronary intervention by drug-eluting balloon angioplasty: The nonrandomized fourth arm of the DEB-AMI (drug-eluting balloon in ST-segment elevation myocardial infarction) trial. Catheter Cardiovasc Interv. 86 (Suppl 1):S34–S44. 2015.PubMed/NCBI View Article : Google Scholar

Vos NS, Fagel ND, Amoroso G, Herrman JR, Patterson MS, Piers LH, van der Schaaf RJ, Slagboom T and Vink MA: Paclitaxel-coated balloon angioplasty versus drug-eluting stent in acute myocardial infarction: The REVELATION randomized trial. JACC Cardiovasc Interv. 12:1691–1699. 2019.PubMed/NCBI View Article : Google Scholar

Scheller B, Ohlow MA, Ewen S, Kische S, Rudolph TK, Clever YP, Wagner A, Richter S, El-Garhy M, Böhm M, et al: Bare metal or drug-eluting stent versus drug-coated balloon in non-ST-elevation myocardial infarction: The randomised PEPCAD NSTEMI trial. EuroIntervention. 15:1527–1533. 2020.PubMed/NCBI View Article : Google Scholar

Liu Y, Zhang YJ, Deng LX, Yin ZY, Hu T, Wang Q, Li Y, Li JY, Guo WY, Mou FJ and Tao L: 12-Month clinical results of drug-coated balloons for de novo coronary lesion in vessels exceeding 3.0 mm. Int J Cardiovasc Imaging. 35:579–586. 2019.PubMed/NCBI View Article : Google Scholar

Venetsanos D, Lawesson SS, Panayi G, Todt T, Berglund U, Swahn E and Alfredsson J: Long-term efficacy of drug coated balloons compared with new generation drug-eluting stents for the treatment of de novo coronary artery lesions. Catheter Cardiovasc Interv. 92:E317–E326. 2018.PubMed/NCBI View Article : Google Scholar

Megaly M, Buda KG, Xenogiannis I, Vemmou E, Nikolakopoulos I, Saad M, Rinfret S, Abbott JD, Aronow HD, Garcia S, et al: Systematic review and meta-analysis of short-term outcomes with drug-coated balloons vs. stenting in acute myocardial infarction. Cardiovasc Interv Ther: Oct 10, 2020 (Epub ahead of print).

Claessen BE, Henriques JP and Dangas GD: Clinical studies with sirolimus, zotarolimus, everolimus, and biolimus A9 drug-eluting stent systems. Curr Pharm Des. 16:4012–4024. 2010.PubMed/NCBI View Article : Google Scholar

Navarese EP, Tandjung K, Claessen B, Andreotti F, Kowalewski M, Kandzari DE, Kereiakes DJ, Waksman R, Mauri L, Meredith IT, et al: Safety and efficacy outcomes of first and second generation durable polymer drug eluting stents and biodegradable polymer biolimus eluting stents in clinical practice: Comprehensive network meta-analysis. BMJ. 347(f6530)2013.PubMed/NCBI View Article : Google Scholar

Sabate M, Raber L, Heg D, Brugaletta S, Kelbaek H, Cequier A, Ostojic M, Iniguez A, Tuller D, Serra A, et al: Comparison of newer-generation drug-eluting with bare-metal stents in patients with acute ST-segment elevation myocardial infarction: A pooled analysis of the EXAMINATION (clinical Evaluation of the Xience-V stent in Acute Myocardial INfArcTION) and COMFORTABLE-AMI (Comparison of Biolimus Eluted From an Erodible Stent Coating With Bare Metal Stents in Acute ST-Elevation Myocardial Infarction) trials. JACC Cardiovasc Interv. 7:55–63. 2014.PubMed/NCBI View Article : Google Scholar